Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van Dam

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancerJosé Baselga, Vladimir Semiglazov, Peter van Dam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2020
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancerSimone N Koole, Leigh Bruijs, Cristina Fabris, et al.
Breast Care (Basel, Switzerland)|April 21, 2025
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in BelgiumRoos Leroy, Cindy De Gendt, Jolyce Bourgeois, et al.
The Plant Journal : for Cell and Molecular Biology|July 21, 2016
Molecular, genetic and evolutionary analysis of a paracentric inversion in Arabidopsis thalianaPaul Fransz, Gabriella Linc, Cheng-Ruei Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - A population-based study in BelgiumRoos Leroy, Geert Silversmit, Jolyce Bourgeois, et al.
Nature Medicine|June 29, 2023
Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarctionSalah S Al-Zaiti, Christian Martin-Gill, Jessica K Zègre-Hemsey, et al.
Breast Cancer Research and Treatment|June 27, 2007
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative studyPatrick Neven, Robert Paridaens, Gino Pelgrims, et al.
Heart Rhythm O2|August 25, 2021
Adaptive Cardiac Resynchronization Therapy Effect on Electrical Dyssynchrony (aCRT-ELSYNC): A randomized controlled trialKazi T Haq, Nichole M Rogovoy, Jason A Thomas, et al.
Cancer Treatment Reviews|October 6, 2022
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancerFrancesco Schettini, Sergio Venturini, Mario Giuliano, et al.
Molecular Oncology|March 16, 2015
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced diseaseMaurice P H M Jansen, Leen Sas, Anieta M Sieuwerts, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancerJosé Baselga, Vladimir Semiglazov, Peter van Dam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2020
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancerSimone N Koole, Leigh Bruijs, Cristina Fabris, et al.
Breast Care (Basel, Switzerland)|April 21, 2025
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in BelgiumRoos Leroy, Cindy De Gendt, Jolyce Bourgeois, et al.
The Plant Journal : for Cell and Molecular Biology|July 21, 2016
Molecular, genetic and evolutionary analysis of a paracentric inversion in Arabidopsis thalianaPaul Fransz, Gabriella Linc, Cheng-Ruei Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - A population-based study in BelgiumRoos Leroy, Geert Silversmit, Jolyce Bourgeois, et al.
Nature Medicine|June 29, 2023
Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarctionSalah S Al-Zaiti, Christian Martin-Gill, Jessica K Zègre-Hemsey, et al.
Breast Cancer Research and Treatment|June 27, 2007
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative studyPatrick Neven, Robert Paridaens, Gino Pelgrims, et al.
Heart Rhythm O2|August 25, 2021
Adaptive Cardiac Resynchronization Therapy Effect on Electrical Dyssynchrony (aCRT-ELSYNC): A randomized controlled trialKazi T Haq, Nichole M Rogovoy, Jason A Thomas, et al.
Cancer Treatment Reviews|October 6, 2022
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancerFrancesco Schettini, Sergio Venturini, Mario Giuliano, et al.
Molecular Oncology|March 16, 2015
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced diseaseMaurice P H M Jansen, Leen Sas, Anieta M Sieuwerts, et al.
Pageof 12